About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Boston | 1,052 Studies

Clinical Trials Breast CancerBoston

Breast Cancer Clinical Trials in Boston

Find 1,052 clinical trials for breast cancer near Boston, Massachusetts. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Boston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 241-260 of 1,052 trials

TerminatedTopical Calcipotriene Treatment for Breast Cancer ImmunopreventionThis research study is studying a topical ointment called calcipotriene to see if it can stimulate the immune cells against the breast lesion in ways that would prevent its…NCT03596073·Boston, Massachusetts RecruitingEvaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical TrialThis research is to evaluate the effectiveness of Talazoparib as a potential treatment for metastatic breast cancer with a BRCA 1 or BRCA 2 mutation.NCT03990896·San Francisco, California and 6 others TerminatedGDC-0084 in Combination With Trastuzumab for Patients With HER2-Positive Breast Cancer Brain MetastasesThis research study is studying a drug called GDC-0084 as a possible treatment for HER2-Positive Breast Cancer.NCT03765983·Boston, Massachusetts WithdrawnChemotherapy and Peripheral Stem Cell Transplantation Followed by Trastuzumab in Treating Women With Metastatic Breast CancerRATIONALE: Chemotherapy uses different ways to stop tumor cells from dividing so they stop growing or die.NCT00006123·Boston, Massachusetts and 1 other

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedA Randomized Phase II Study Of Eribulin Mesylate With or Without Pembrolizumab For Metastatic Hormone Receptor Positive Breast CancerThis research study is exploring chemotherapy in combination with immunotherapy (a therapy that uses the body's own immune system to control cancer) as a possible treatment for…NCT03051659·Boston, Massachusetts and 2 others

Active not recruitingThe Young Women's Breast Cancer StudyThe investigators are conducting a longitudinal cohort study of young women with breast cancer.NCT01468246·Aurora, Colorado and 12 others

Active not recruitingThe Preoperative Health & Body StudyThis study is designed to look at the changes that occur in women who take part in exercise and Mind-Body programs between breast cancer diagnosis and breast surgery.NCT01516190·Boston, Massachusetts

TerminatedA Breast Cancer Treatment Decision Aid for Women Aged 70 and OlderThe purpose of this research study is to evaluate a decision aid to help women aged 70 and older decide on treatment for their breast cancer.NCT02823262·Boston, Massachusetts and 1 other

Active not recruitingStudy of Trastuzumab Deruxtecan (T-DXd) vs Investigator's Choice Chemotherapy in HER2-low, Hormone Receptor Positive, Metastatic Breast CancerThis study will evaluate the efficacy, safety and tolerability of trastuzumab deruxtecan compared with investigator's choice chemotherapy in human epidermal growth factor receptor…NCT04494425·Scottsdale, Arizona and 292 others

TerminatedStudy of Olaparib Plus Pembrolizumab Versus Chemotherapy Plus Pembrolizumab After Induction With First-Line Chemotherapy Plus Pembrolizumab in Triple Negative Breast Cancer (TNBC) (MK-7339-009/KEYLYNK-009)The purpose of this study is to compare the efficacy of olaparib (MK-7339) plus pembrolizumab (MK-3475) with chemotherapy plus pembrolizumab after induction with first-line…NCT04191135·Monterey, California and 121 others

CompletedTissue Oxygenation Measurements With Modulated Light (S-FLARE)To perform a pilot study of the S-FLARE imaging system, which uses low levels of safe, invisible, near-infrared light to measure tissue oxygenation during breast reconstructive…NCT01116297·Boston, Massachusetts

CompletedCulturally Aware AET Non-Initiation InterventionThe purpose of this study is to examine the feasibility and acceptability of a brief, nurse-led intervention to support breast cancer survivors who have delayed initiation of…NCT05465408·Boston, Massachusetts and 10 others

CompletedStudy of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer SurvivorsThis randomized phase II trial studies how well docosahexaenoic acid works in preventing recurrence in breast cancer survivors.NCT01849250·Boston, Massachusetts and 3 others

TerminatedPhase II PEMBROLIZUMAB + PALLIATIVE RADIOTHERAPY IN BCThis research study is studying radiation therapy in combination with an immunotherapy as a possible treatment for metastatic hormone receptor (HR) positive, HER2-negative breast…NCT03051672·Boston, Massachusetts

Active not recruitingUnderstanding and Predicting Breast Cancer Events After TreatmentThis study is being done to see if patients receiving chemotherapy for breast cancer affects the heart, the ability to exercise and fatigue when compared to patients who do not…NCT02791581·Birmingham, Alabama and 65 others

CompletedDecisions About Cancer Screening in Alzheimer's DiseaseThe Decisions about Cancer screening in Alzheimer's Disease (DECAD) study tests if an evidence-based decision aid for dementia caregivers can support decision-making about…NCT03282097·Fort Wayne, Indiana and 4 others

RecruitingAdding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast CancerThis phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint High 2…NCT06058377·Birmingham, Alabama and 564 others

TerminatedA Study to Evaluate the Safety, Pharmacokinetics and Clinical Activity of RO6870810 and Atezolizumab (PD-L1 Antibody) in Participants With Advanced Ovarian Cancer or Triple Negative Breast CancerThis is Phase IB, open label, non-randomized study designed to investigate the dose, safety, pharmacokinetics and anti-tumor activity of RO6870810 in combination with a fixed dose…NCT03292172·Boston, Massachusetts and 10 others

CompletedA Study of Palbociclib in Combination With Fulvestrant or Tamoxifen as Treatment for Metastatic Breast CancerThis phase II trial studies the side effects of palbociclib when given together with fulvestrant or tamoxifen citrate in treating patients with hormone receptor positive breast…NCT02384239·San Francisco, California and 8 others

RecruitingSafety and Tolerability of TNG462 in Patients With MTAP-deleted Solid TumorsThis is a first in human study in patients with advanced or metastatic solid tumors known to have an MTAP deletion.NCT05732831·Palo Alto, California and 25 others

PreviousPage 13 of 53Next

Other Conditions in Boston

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma